Researchers develop PrecisionView, a handheld AI-powered endomicroscope for real-time, high-resolution cancer diagnostics.
Key Details
- 1PrecisionView combines advanced optics and deep learning to image cellular and vascular structures non-invasively.
- 2Delivers a field of view five times, and depth of field eight times, greater than traditional in vivo microscopy.
- 3Displays real-time images at up to 15 frames per second, enabling clinicians to examine several square centimeters in one scan.
- 4Validated in healthy volunteers and human tissue samples, successfully identifying precancerous and cancerous lesions.
- 5The device is both compact (about the size of a pen) and low-cost (~$3,000), making it suitable for low-resource settings.
- 6Backed by Rice University, MD Anderson Cancer Center, NIH, NCI, and DARPA funding; larger clinical studies pending.
Why It Matters
This technology could significantly improve early cancer detection by making high-resolution microscopy portable, affordable, and usable at the point of care, especially in underserved regions. Integration of AI and hardware design sets a new paradigm for imaging devices in clinical oncology.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.